CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $50,000 | -65.0% | 17,000 | -45.2% | 0.00% | -60.0% |
| Q2 2020 | $143,000 | +20.2% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $119,000 | +9.2% | 31,000 | +6.9% | 0.01% | +25.0% |
| Q4 2019 | $109,000 | -29.2% | 29,000 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $154,000 | +38.7% | 29,000 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $111,000 | -19.6% | 29,000 | +7.4% | 0.00% | -20.0% |
| Q1 2019 | $138,000 | +165.4% | 27,000 | 0.0% | 0.01% | +150.0% |
| Q4 2018 | $52,000 | -46.9% | 27,000 | +3.8% | 0.00% | -33.3% |
| Q3 2018 | $98,000 | +21.0% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $81,000 | +30.6% | 26,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $62,000 | -39.2% | 26,000 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $102,000 | +54.5% | 26,000 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $66,000 | -8.3% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $72,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |